Literature DB >> 3930288

Glucuronidation of bile acids in human liver, intestine and kidney. An in vitro study on hyodeoxycholic acid.

M Parquet, M Pessah, E Sacquet, C Salvat, A Raizman, R Infante.   

Abstract

The activities of UDP-glucuronyl transferase(s) in homogenates and microsomal preparations of human liver, kidney and intestine were tested with hyodeoxycholic acid (HDC). The various kinetic parameters of the UDC-glucuronidation were determined from time course experiments. In both liver and kidney preparations, HDC underwent a very active metabolic transformation: liver Km = 78 microM, Vmax = 3.3 nmol . min-1 . mg-1 protein; kidney Km = 186 microM, Vmax = 9.9 nmol . min-1 . mg-1 protein. To our knowledge this is the first observation of both an extensive and comparable bile acid glucuronidation occurring in renal and hepatic tissues.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930288     DOI: 10.1016/0014-5793(85)81020-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  Cloning of a human liver microsomal UDP-glucuronosyltransferase cDNA.

Authors:  M R Jackson; L R McCarthy; D Harding; S Wilson; M W Coughtrie; B Burchell
Journal:  Biochem J       Date:  1987-03-01       Impact factor: 3.857

2.  A model of in vitro UDP-glucuronosyltransferase inhibition by bile acids predicts possible metabolic disorders.

Authors:  Zhong-Ze Fang; Rong-Rong He; Yun-Feng Cao; Naoki Tanaka; Changtao Jiang; Kristopher W Krausz; Yunpeng Qi; Pei-Pei Dong; Chun-Zhi Ai; Xiao-Yu Sun; Mo Hong; Guang-Bo Ge; Frank J Gonzalez; Xiao-Chi Ma; Hong-Zhi Sun
Journal:  J Lipid Res       Date:  2013-10-10       Impact factor: 5.922

3.  Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells.

Authors:  D Harding; S Fournel-Gigleux; M R Jackson; B Burchell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

4.  Glucuronidation of 6 alpha-hydroxy bile acids by human liver microsomes.

Authors:  A Radomińska-Pyrek; P Zimniak; Y M Irshaid; R Lester; T R Tephly; J St Pyrek
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

Review 5.  Intestinal transport and metabolism of bile acids.

Authors:  Paul A Dawson; Saul J Karpen
Journal:  J Lipid Res       Date:  2014-09-10       Impact factor: 5.922

Review 6.  Farnesoid X Receptor an Emerging Target to Combat Obesity.

Authors:  C Daniel De Magalhaes Filho; Michael Downes; Ronald M Evans
Journal:  Dig Dis       Date:  2017-03-01       Impact factor: 2.404

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.